🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 1 día
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
31/01/2019 0,3416 USD
08/11/2018 0,3226 USD
02/08/2018 0,3226 USD
10/05/2018 0,3226 USD
01/02/2018 0,3226 USD
09/11/2017 0,3036 USD
02/08/2017 0,3036 USD
10/05/2017 0,3036 USD
01/02/2017 0,3036 USD
08/11/2016 0,2846 USD
03/08/2016 0,2846 USD
11/05/2016 0,2846 USD
03/02/2016 0,2846 USD
04/11/2015 0,2657 USD
05/08/2015 0,2657 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/02/2006 23,77 24,38 23,76 23,89 +0,36% 2,63% 30.249.695
06/02/2006 23,92 24,02 23,67 23,80 -0,75% 1,47% 22.949.691
03/02/2006 24,46 24,46 23,98 23,98 -1,94% 1,98% 28.986.476
02/02/2006 24,76 24,79 24,24 24,46 -1,04% 2,22% 26.013.669
01/02/2006 24,43 24,78 24,36 24,72 +1,44% 1,71% 29.909.569
31/01/2006 24,69 24,73 24,20 24,36 -1,00% 2,15% 33.058.288
30/01/2006 24,81 24,99 24,44 24,61 -0,19% 2,22% 34.604.085
27/01/2006 24,15 24,74 24,05 24,66 +3,75% 2,87% 64.305.699
26/01/2006 23,67 24,04 23,52 23,77 +0,89% 2,20% 43.476.973
25/01/2006 23,45 23,60 23,05 23,56 +0,98% 2,35% 27.793.137
24/01/2006 23,72 23,75 23,24 23,33 -1,21% 2,12% 30.770.687
23/01/2006 23,53 23,71 23,48 23,61 +0,73% 0,97% 30.375.331
20/01/2006 23,69 23,79 23,36 23,44 -1,04% 1,80% 54.431.933
19/01/2006 23,63 23,83 23,37 23,69 +4,04% 1,97% 60.725.999
18/01/2006 22,95 22,99 22,63 22,77 -1,15% 1,57% 35.290.555
17/01/2006 23,25 23,27 22,84 23,04 -1,58% 1,88% 33.888.840
13/01/2006 23,43 23,52 23,19 23,41 +0,37% 1,42% 22.103.434
12/01/2006 23,50 23,58 23,22 23,32 -0,69% 1,53% 28.479.396
11/01/2006 23,34 23,56 23,29 23,48 +1,27% 1,14% 29.954.680
10/01/2006 23,46 23,47 23,07 23,19 -1,65% 1,70% 30.171.172
09/01/2006 23,70 23,71 23,26 23,58 +0,00% 1,88% 29.596.215
06/01/2006 23,43 23,67 23,37 23,58 +1,10% 1,30% 30.064.191
05/01/2006 23,29 23,48 23,19 23,32 +0,12% 1,26% 44.900.716
04/01/2006 22,74 23,31 22,72 23,29 +3,24% 2,59% 46.345.961
03/01/2006 22,44 22,69 22,39 22,56 +1,97% 1,35% 40.104.489
30/12/2005 22,27 22,27 22,02 22,13 -0,55% 1,11% 34.248.044
29/12/2005 22,34 22,43 22,24 22,25 -0,64% 0,85% 26.156.064
28/12/2005 22,46 22,59 22,34 22,39 -0,13% 1,10% 25.369.253
27/12/2005 22,73 22,77 22,42 22,42 -1,38% 1,54% 26.304.151
23/12/2005 22,77 22,82 22,66 22,73 -0,42% 0,71% 22.781.788